239 related articles for article (PubMed ID: 22582077)
41. [Lactobacillus inhibit adhesion of Staphylococcus aureus to HeLa cells].
Wang J; Zhang R; Zhou L; Su X; Hu C; Zhu B; Feng T
Sheng Wu Gong Cheng Xue Bao; 2012 Jun; 28(6):715-25. PubMed ID: 23016308
[TBL] [Abstract][Full Text] [Related]
42. In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes.
Gobbi E; De Francesco MA; Piccinelli G; Caruso A; Bardellini E; Majorana A
Eur Arch Paediatr Dent; 2020 Dec; 21(6):673-677. PubMed ID: 32034698
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice.
Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS
BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067
[TBL] [Abstract][Full Text] [Related]
44. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
45. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
46. Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study.
Twetman L; Larsen U; Fiehn NE; Stecksén-Blicks C; Twetman S
Acta Odontol Scand; 2009; 67(5):284-8. PubMed ID: 19479452
[TBL] [Abstract][Full Text] [Related]
47. Interaction between Lactobacillus reuteri and periodontopathogenic bacteria using in vitro and in vivo (G. mellonella) approaches.
Santos TA; Scorzoni L; Correia R; Junqueira JC; Anbinder AL
Pathog Dis; 2020 Nov; 78(8):. PubMed ID: 32845308
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri.
Laughton JM; Devillard E; Heinrichs DE; Reid G; McCormick JK
Microbiology (Reading); 2006 Apr; 152(Pt 4):1155-1167. PubMed ID: 16549678
[TBL] [Abstract][Full Text] [Related]
49. Autolyse the cell in order to save it? Inducing, then blocking, autolysis as a strategy for delaying cell death in the probiotic Lactobacillus reuteri.
Zimmerman T; Gyawali R; Ibrahim S
Biotechnol Lett; 2017 Oct; 39(10):1547-1551. PubMed ID: 28623443
[TBL] [Abstract][Full Text] [Related]
50. Properties of Lactobacillus reuteri chitosan-calcium-alginate encapsulation under simulated gastrointestinal conditions.
Huang HY; Tang YJ; King VA; Chou JW; Tsen JH
Int Microbiol; 2015 Mar; 18(1):61-9. PubMed ID: 26415668
[TBL] [Abstract][Full Text] [Related]
51. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
[TBL] [Abstract][Full Text] [Related]
52. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
53. Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice.
Eaton KA; Honkala A; Auchtung TA; Britton RA
Infect Immun; 2011 Jan; 79(1):185-91. PubMed ID: 20974822
[TBL] [Abstract][Full Text] [Related]
54. The characteristics of lactic acid bacteria isolated from fermented food as potential probiotics.
Fitriani VY; Suprapti B; Amin M
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):743-749. PubMed ID: 34214350
[TBL] [Abstract][Full Text] [Related]
55. Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes.
Li L; Fang Z; Liu X; Hu W; Lu W; Lee YK; Zhao J; Zhang H; Chen W
PLoS One; 2020; 15(4):e0231865. PubMed ID: 32315360
[TBL] [Abstract][Full Text] [Related]
56. Cell-Free Lactobacillus sp Supernatants Modulate Staphylococcus aureus Growth, Adhesion and Invasion to Human Osteoblast (HOB) Cells.
Kalaycı Yüksek F; Gümüş D; Gündoğan Gİ; Anğ Küçüker M
Curr Microbiol; 2021 Jan; 78(1):125-132. PubMed ID: 33108492
[TBL] [Abstract][Full Text] [Related]
57. Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Romani Vestman N; Hasslöf P; Keller MK; Granström E; Roos S; Twetman S; Stecksén-Blicks C
Caries Res; 2013; 47(4):338-45. PubMed ID: 23486236
[TBL] [Abstract][Full Text] [Related]
58. Effect of Lactobacillus reuteri on the proliferation of Propionibacterium acnes and Staphylococcus epidermidis.
Kang MS; Oh JS; Lee SW; Lim HS; Choi NK; Kim SM
J Microbiol; 2012 Feb; 50(1):137-42. PubMed ID: 22367948
[TBL] [Abstract][Full Text] [Related]
59. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.
Fåk F; Bäckhed F
PLoS One; 2012; 7(10):e46837. PubMed ID: 23056479
[TBL] [Abstract][Full Text] [Related]
60. The effect of calcium ions on adhesion and competitive exclusion of Lactobacillus ssp. and E. coli O138.
Larsen N; Nissen P; Willats WG
Int J Food Microbiol; 2007 Feb; 114(1):113-9. PubMed ID: 17234293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
